Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last A$2.78 AUD
Change Today -0.05 / -1.77%
Volume 4.7M
HSO On Other Exchanges
Symbol
Exchange
OTC US
Frankfurt
As of 2:10 AM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

healthscope ltd (HSO) Snapshot

Open
A$2.79
Previous Close
A$2.83
Day High
A$2.82
Day Low
A$2.77
52 Week High
03/3/15 - A$3.15
52 Week Low
07/28/14 - A$2.09
Market Cap
4.8B
Average Volume 10 Days
3.9M
EPS TTM
A$-0.04
Shares Outstanding
1.7B
EX-Date
03/5/15
P/E TM
--
Dividend
A$0.03
Dividend Yield
1.19%
Current Stock Chart for HEALTHSCOPE LTD (HSO)

Related News

No related news articles were found.

healthscope ltd (HSO) Related Businessweek News

No Related Businessweek News Found

healthscope ltd (HSO) Details

Healthscope Limited provides private health care services. The company’s Hospitals segment offers medical and surgical services in the fields of intensive care, maternity, cardiac, orthopaedics, urology, oral, gynaecology, endoscopy, vascular, and ear, nose, and throat surgery, as well as provides general, plastic, other specialist and day surgery. This segment also provides treatment for anxiety, depression, schizophrenia, post-traumatic stress, eating disorders, alcohol and drug addiction, and obsessive compulsive disorders; and rehabilitation services for patients with acquired brain injury, musculoskeletal injuries, cardiac and stroke, and pain management. It operates 44 private hospitals with approximately 4,400 beds, including 31 acute hospitals, 7 psychiatric hospitals, and 6 rehabilitation and extended care facilities, as well as operates independent living housing facilities. Its International Pathology segment provides various pathology services primarily under the Labtests, SCL, and Northland brands; and general practitioner, specialist, hospital, and corporate screening services, as well as offers women’s and children’s health services. It operates 13 laboratories in New Zealand; 26 laboratories in Malaysia; and 1 central laboratory in Singapore, as well as manages 1 laboratory in Vietnam. The company’s Australian Pathology segment provides anatomical, biochemistry, haematology, microbiology, and molecular pathology services; and general practice management services, as well as operates one specialist breast diagnostic clinic in Sydney. As of May 19, 2014, it operated 578 collection centers and 69 accredited laboratories; and 46 medical centers and 11 specialist skin cancer clinics. The company was formerly known as Healthscope Hospitals Holdings Pty. Ltd. Healthscope Limited was founded in 1985 and is based in Melbourne, Australia. Healthscope Limited operates as a subsidiary of Healthscope Group.

Founded in 1985

healthscope ltd (HSO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

healthscope ltd (HSO) Key Developments

Healthscope Limited Presents at 12th Annual Australia & New Zealand Investment Conference, Mar-09-2015

Healthscope Limited Presents at 12th Annual Australia & New Zealand Investment Conference, Mar-09-2015 . Venue: The Corinthia Hotel, 10 Whitehall Place, London SW1A 2BD, United Kingdom. Speakers: Anita Healy, GM Business Development & Investor Relations, Michael Sammells, Chief Financial Officer.

Healthscope Limited Announces Interim Dividend, Payable on or About March 24, 2015

Healthscope Limited announced interim dividend of $0.0330 per security. Ex-distribution/entitlement date is March 5, 2015. Record date is March 10, 2015. Payable on or about March 24, 2015.

Healthscope Limited Announces Interim Unfranked Dividend, Payable on March 24, 2015

Healthscope Limited announced interim dividend of 3.3 cents per share in-line with stated dividend payout ratio of 70% of pro-forma NPAT. The dividend will be paid on March 24, 2015 on the record date of March 10, 2015 with the Ex-dividend date of March 05, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HSO:AU A$2.78 AUD -0.05

HSO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Primary Health Care Ltd A$5.07 AUD -0.06
Sonic Healthcare Ltd A$19.53 AUD -0.33
View Industry Companies
 

Industry Analysis

HSO

Industry Average

Valuation HSO Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEALTHSCOPE LTD, please visit www.healthscope.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.